首页 > 最新文献

Nutricion hospitalaria最新文献

英文 中文
Adaptation and validation of the Brief Questionnaire for Measuring Disordered Eating Behaviors in Mexican children. 墨西哥儿童饮食紊乱行为简明测量问卷的改编和验证。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05288
Claudia Unikel Santoncini, Iraís Castillo Rangel, Miriam Wendolyn Barajas Márquez, Leticia Adriana Rivera Castañeda, Ana Berenice Casillas Arias

Introduction: Introduction: disordered eating behaviors (DEBs) and eating disorders (Eds) mainly occur in adolescence, but they currently already occur at an early age between the ages of five and twelve. Although there are instruments for EDs, it is necessary to have a self-applicable instrument for evaluating DEBs in children. Objective: to determine the reliability and exploratory and confirmatory factorial validity of the Brief Questionnaire for Measuring Disordered Eating Behaviors (BQDEB) in children ages eight to twelve years. Material and methods: the sample comprised 386 Mexican children with an average age of 10.2 years. The BQDEB was adapted for this population, with questions being reduced from ten to seven and answer choices from four to three. Frequency and percentage, reliability, and exploratory and confirmatory validity analyses were undertaken. Results: concern over gaining weight was the most frequent DEB. The exploratory factorial analysis yielded seven items grouped into two factors: 1) compensatory/restrictive behaviors; and 2) binge eating, with a total ordinal alpha reliability of 0.95. Confirmatory factor analysis showed that the model fits the data well. Conclusions: since the psychometric properties of the BQDEB for children were adequate, it constitutes a useful instrument for identifying DEBs in children.

导言:饮食行为紊乱(DEBs)和饮食失调(Eds)主要发生在青春期,但目前在五岁至十二岁的早期就已经出现。目的:确定测量饮食失调行为简明问卷(BQDEB)在 8 至 12 岁儿童中的可靠性、探索性和确认性因子效度。材料和方法:样本包括 386 名墨西哥儿童,平均年龄为 10.2 岁。对 BQDEB 进行了改编,问题从 10 个减少到 7 个,答案选项从 4 个减少到 3 个。结果显示:担心体重增加是最常见的 DEB。探索性因子分析得出了七个项目,分为两个因子:1)补偿/限制行为;2)暴饮暴食,总序数α信度为 0.95。结论:由于儿童 BQDEB 的心理测量特性良好,因此它是识别儿童 DEB 的有效工具。
{"title":"Adaptation and validation of the Brief Questionnaire for Measuring Disordered Eating Behaviors in Mexican children.","authors":"Claudia Unikel Santoncini, Iraís Castillo Rangel, Miriam Wendolyn Barajas Márquez, Leticia Adriana Rivera Castañeda, Ana Berenice Casillas Arias","doi":"10.20960/nh.05288","DOIUrl":"10.20960/nh.05288","url":null,"abstract":"<p><strong>Introduction: </strong>Introduction: disordered eating behaviors (DEBs) and eating disorders (Eds) mainly occur in adolescence, but they currently already occur at an early age between the ages of five and twelve. Although there are instruments for EDs, it is necessary to have a self-applicable instrument for evaluating DEBs in children. Objective: to determine the reliability and exploratory and confirmatory factorial validity of the Brief Questionnaire for Measuring Disordered Eating Behaviors (BQDEB) in children ages eight to twelve years. Material and methods: the sample comprised 386 Mexican children with an average age of 10.2 years. The BQDEB was adapted for this population, with questions being reduced from ten to seven and answer choices from four to three. Frequency and percentage, reliability, and exploratory and confirmatory validity analyses were undertaken. Results: concern over gaining weight was the most frequent DEB. The exploratory factorial analysis yielded seven items grouped into two factors: 1) compensatory/restrictive behaviors; and 2) binge eating, with a total ordinal alpha reliability of 0.95. Confirmatory factor analysis showed that the model fits the data well. Conclusions: since the psychometric properties of the BQDEB for children were adequate, it constitutes a useful instrument for identifying DEBs in children.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1294-1299"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario]. [GLP-1类似物之争:在真实世界场景中,塞马鲁肽0.5毫克/周和利拉鲁肽3毫克/天在3个月后对人体测量参数的影响]。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05244
Antelm Pujol Calafat, Joana Nicolau, Apolonia Gil, Jorge Blanco Anesto

Introduction: Background: the prevalence of obesity is reaching a pandemic status. The SCALE trials showed that liraglutide 3 mg among people with obesity (PwO) was effective to reduce bodyweight and related complications. The fact that almost two-thirds of patients did not achieve the desired weight loss with the maximum dose of liraglutide made almost mandatory the development of other pharmacological options. The STEP 1-5 trials showed the effectiveness of semaglutide in reducing bodyweight in a dose-dependent manner. Moreover, the STEP 8 trial proved the superiority of semaglutide 2,4 mg/week versus liraglutide 3 mg/daily. We aimed to assess the effects of subcutaneous (s.c.) semaglutide 0.5 mg/weekly compared with s.c. liraglutide 3 mg/daily in PwO on anthropometric parameters in a real world-scenario for 3 months. Methods: we retrospectively evaluated 179 PwO (91.9 % ♀, 45.7 ± 10 years, and 33.3 ± 7 kg/m2) who received treatment with aGLP-1 as add-on therapy to lifestyle interventions. Patients were evaluated at baseline and after 3 months. Ninety-nine patients were prescribed s.c. semaglutide 0.5 mg/weekly with an off-label indication for weight reduction. These patients were compared with 80 patients treated with s.c. liraglutide 3 mg/daily. The main reason for prescribing of s.c. semaglutide was economic. Body composition was evaluated using a bioimpedance device (Tanita MC 580M®). Results: baseline weight was significantly greater with semaglutide compared to liraglutide (97.19 ± 21.09 vs. 90.73 ± 21.88 kg; p < 0.01) as was fat mass (42.43 ± 15.04 vs. 34.84 ± 16.07 kg; p < 0.01), whereas baseline lean mass was lesser among subjects treated with semaglutide (31.62 ± 7.56 vs 45.69 ± 15.51 kg; p < 0.01). PwO experienced a significant reduction in weight using s.c. semaglutide 0.5 mg/weekly (96.67 ± 20.83 vs. 91.44 ± 19.6 kg; p < 0.01) or s.c. liraglutide 3 mg/daily (90.73 ± 21.88 vs. 80.13 ± 18.38 kg; p < 0.01) No significant differences were seen between the amount of weight lost (5.28 ± 4.22 vs 5.72 ± 1.62 kg; p = 0.5) in the two groups. Furthermore, both groups were comparable in fat mass (2.69 ± 5.34 vs 0.96 ± 4.22 kg; p = 0.3) and fat-free mass (0.86 ± 1.63 vs 1.03 ± 0.94 kg; p = 0.07) after 3 months of treatment with both aGLP1. Side effects were gastrointestinal and transient/comparable between groups Conclusions: subcutaneous semaglutide 0.5 mg and subcutaneous liraglutide 3 mg are effective treatments for reducing weight safely among PwO in a real-world scenario at short term and without a negative impact on fat-free mass. Moreover, low doses of semaglutide were similar to liraglutide 3 mg in reducing bodyweight at short term.

背景:肥胖症的发病率已达到大流行病的程度。SCALE试验表明,3毫克利拉鲁肽对肥胖症患者(PwO)有效,能减轻体重并减少相关并发症。由于近三分之二的患者在服用最大剂量的利拉鲁肽后体重没有达到理想的减轻效果,因此几乎必须开发其他药物治疗方案。STEP 1-5 试验表明,塞马鲁肽能以剂量依赖的方式有效减轻体重。此外,STEP 8 试验证明,与利拉鲁肽 3 毫克/天的剂量相比,塞马鲁肽 2.4 毫克/周的剂量更具优势。我们的目的是评估在真实世界场景中,与利拉鲁肽 3 毫克/天皮下注射相比,塞马鲁肽 0.5 毫克/周皮下注射对 PwO 人体测量参数的影响,为期 3 个月。方法:我们回顾性评估了 179 名接受 aGLP-1 作为生活方式干预附加疗法的 PwO(91.9 % ♀,45.7 ± 10 岁,33.3 ± 7 kg/m2)。对患者进行了基线评估和 3 个月后的评估。99名患者接受了semaglutide 0.5 mg/周的静脉注射治疗,标签外适应症为减轻体重。这些患者与接受利拉鲁肽静脉注射 3 毫克/天治疗的 80 名患者进行了比较。开具西药塞马鲁肽处方的主要原因是经济因素。使用生物阻抗仪(Tanita MC 580M®)评估身体成分。结果:与利拉鲁肽相比,使用塞马鲁肽的基线体重明显增加(97.19 ± 21.09 vs. 90.73 ± 21.88 kg; p < 0.01),脂肪量(42.43 ± 15.04 vs. 34.84 ± 16.07 kg; p < 0.01)也是如此,而使用塞马鲁肽治疗的受试者基线瘦肉量较少(31.62 ± 7.56 vs. 45.69 ± 15.51 kg; p < 0.01)。使用塞马鲁肽 0.5 毫克/周(96.67 ± 20.83 vs 91.44 ± 19.6 千克;p < 0.01)或利拉鲁肽 3 毫克/天(90.73 ± 21.88 vs 80.13 ± 18.38 千克;p < 0.01)的 PwO 体重明显减轻,但两组的体重减轻量无明显差异(5.28 ± 4.22 vs 5.72 ± 1.62 千克;p = 0.5)。此外,在使用两种 aGLP1 治疗 3 个月后,两组的脂肪量(2.69 ± 5.34 vs 0.96 ± 4.22 kg;p = 0.3)和去脂量(0.86 ± 1.63 vs 1.03 ± 0.94 kg;p = 0.07)相当。结论:在现实世界中,皮下注射 0.5 毫克的semaglutide 和 3 毫克的利拉鲁肽是在短期内安全减轻体重的有效治疗方法,而且不会对去脂体重产生负面影响。此外,在短期减轻体重方面,低剂量的塞马鲁肽与3毫克的利拉鲁肽效果相似。
{"title":"[The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario].","authors":"Antelm Pujol Calafat, Joana Nicolau, Apolonia Gil, Jorge Blanco Anesto","doi":"10.20960/nh.05244","DOIUrl":"10.20960/nh.05244","url":null,"abstract":"<p><strong>Introduction: </strong>Background: the prevalence of obesity is reaching a pandemic status. The SCALE trials showed that liraglutide 3 mg among people with obesity (PwO) was effective to reduce bodyweight and related complications. The fact that almost two-thirds of patients did not achieve the desired weight loss with the maximum dose of liraglutide made almost mandatory the development of other pharmacological options. The STEP 1-5 trials showed the effectiveness of semaglutide in reducing bodyweight in a dose-dependent manner. Moreover, the STEP 8 trial proved the superiority of semaglutide 2,4 mg/week versus liraglutide 3 mg/daily. We aimed to assess the effects of subcutaneous (s.c.) semaglutide 0.5 mg/weekly compared with s.c. liraglutide 3 mg/daily in PwO on anthropometric parameters in a real world-scenario for 3 months. Methods: we retrospectively evaluated 179 PwO (91.9 % ♀, 45.7 ± 10 years, and 33.3 ± 7 kg/m2) who received treatment with aGLP-1 as add-on therapy to lifestyle interventions. Patients were evaluated at baseline and after 3 months. Ninety-nine patients were prescribed s.c. semaglutide 0.5 mg/weekly with an off-label indication for weight reduction. These patients were compared with 80 patients treated with s.c. liraglutide 3 mg/daily. The main reason for prescribing of s.c. semaglutide was economic. Body composition was evaluated using a bioimpedance device (Tanita MC 580M®). Results: baseline weight was significantly greater with semaglutide compared to liraglutide (97.19 ± 21.09 vs. 90.73 ± 21.88 kg; p < 0.01) as was fat mass (42.43 ± 15.04 vs. 34.84 ± 16.07 kg; p < 0.01), whereas baseline lean mass was lesser among subjects treated with semaglutide (31.62 ± 7.56 vs 45.69 ± 15.51 kg; p < 0.01). PwO experienced a significant reduction in weight using s.c. semaglutide 0.5 mg/weekly (96.67 ± 20.83 vs. 91.44 ± 19.6 kg; p < 0.01) or s.c. liraglutide 3 mg/daily (90.73 ± 21.88 vs. 80.13 ± 18.38 kg; p < 0.01) No significant differences were seen between the amount of weight lost (5.28 ± 4.22 vs 5.72 ± 1.62 kg; p = 0.5) in the two groups. Furthermore, both groups were comparable in fat mass (2.69 ± 5.34 vs 0.96 ± 4.22 kg; p = 0.3) and fat-free mass (0.86 ± 1.63 vs 1.03 ± 0.94 kg; p = 0.07) after 3 months of treatment with both aGLP1. Side effects were gastrointestinal and transient/comparable between groups Conclusions: subcutaneous semaglutide 0.5 mg and subcutaneous liraglutide 3 mg are effective treatments for reducing weight safely among PwO in a real-world scenario at short term and without a negative impact on fat-free mass. Moreover, low doses of semaglutide were similar to liraglutide 3 mg in reducing bodyweight at short term.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1224-1230"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the link between the Naples prognostic score and the cardio-ankle vascular index. 探索那不勒斯预后评分与心踝关节血管指数之间的联系。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05318
Ercan Aydın, Savaş Özer, Ahmet Özderya, Emre Yılmaz, Armağan Kaya, Altuğ Ösken, Gökhan Yerlikaya, Selçuk Yaylacı

Introduction: Background: the Naples Prognostic Score is a novel scoring system designed to provide a comprehensive assessment of patients' inflammation and nutritional status. Aim: our aim was to investigate the correlation between the Naples Prognostic Score and arterial stiffness, a factor known to be linked with heart failure and acute coronary syndrome. Materials and methods: this prospective study included 142 consecutive patients without a history of cardiovascular disease, inflammatory disease, immunological disease, malignancy, or comorbid conditions other than hypertension. Patients were categorized into two groups based on their Naples Prognostic Scores: Group 1 (score of 0-2) and Group 2 (score of 3 or 4). Arterial stiffness was assessed using the Cardio-Ankle Vascular Index (CAVI) measured with the VaSera VS-1000 device. CAVI values were compared between the groups. Results: the mean age of the patients was 54 ± 9 years. Group 1 comprised 114 (80.3 %) patients, while Group 2 comprised 28 (19.7 %) patients. There were no significant differences in demographic data between the groups (p > 0.005). Additionally, there were no statistically significant differences between Group 1 and Group 2 regarding left CAVI (7.92 ± 1.45 vs. 8.72 ± 1.85; p = 0.295), right CAVI (7.89 ± 1.52 vs. 8.67 ± 1.34; p = 0.332), or left or right ankle brachial index (p > 0.005). Conclusions: despite previous studies indicating a significant association between the Naples Prognostic Score and heart failure or acute coronary syndrome, our study did not observe a significant correlation between this score and arterial stiffness assessed by CAVI.

背景:那不勒斯预后评分(Naples Prognostic Score)是一种新型评分系统,旨在对患者的炎症和营养状况进行综合评估。目的:我们的目的是研究那不勒斯预后评分与动脉僵化之间的相关性,动脉僵化是已知与心力衰竭和急性冠状动脉综合征相关的因素。材料和方法:这项前瞻性研究纳入了 142 名连续患者,他们均无心血管疾病、炎症性疾病、免疫性疾病、恶性肿瘤或高血压以外的合并症病史。根据那不勒斯预后评分将患者分为两组:第 1 组(0-2 分)和第 2 组(3 分或 4 分)。动脉僵硬度使用 VaSera VS-1000 设备测量的心-踝血管指数 (CAVI) 进行评估。结果:患者的平均年龄为 54 ± 9 岁。第一组有 114 名患者(80.3%),第二组有 28 名患者(19.7%)。两组患者的人口统计学数据无明显差异(P > 0.005)。此外,第 1 组和第 2 组在左侧 CAVI(7.92 ± 1.45 vs. 8.72 ± 1.85;p = 0.295)、右侧 CAVI(7.89 ± 1.52 vs. 8.67 ± 1.34;p = 0.332)、左右踝肱指数方面均无明显统计学差异(p > 0.005)。结论:尽管之前的研究表明那不勒斯预后评分与心力衰竭或急性冠状动脉综合征之间存在显著关联,但我们的研究并未观察到该评分与 CAVI 评估的动脉僵化之间存在显著关联。
{"title":"Exploring the link between the Naples prognostic score and the cardio-ankle vascular index.","authors":"Ercan Aydın, Savaş Özer, Ahmet Özderya, Emre Yılmaz, Armağan Kaya, Altuğ Ösken, Gökhan Yerlikaya, Selçuk Yaylacı","doi":"10.20960/nh.05318","DOIUrl":"10.20960/nh.05318","url":null,"abstract":"<p><strong>Introduction: </strong>Background: the Naples Prognostic Score is a novel scoring system designed to provide a comprehensive assessment of patients' inflammation and nutritional status. Aim: our aim was to investigate the correlation between the Naples Prognostic Score and arterial stiffness, a factor known to be linked with heart failure and acute coronary syndrome. Materials and methods: this prospective study included 142 consecutive patients without a history of cardiovascular disease, inflammatory disease, immunological disease, malignancy, or comorbid conditions other than hypertension. Patients were categorized into two groups based on their Naples Prognostic Scores: Group 1 (score of 0-2) and Group 2 (score of 3 or 4). Arterial stiffness was assessed using the Cardio-Ankle Vascular Index (CAVI) measured with the VaSera VS-1000 device. CAVI values were compared between the groups. Results: the mean age of the patients was 54 ± 9 years. Group 1 comprised 114 (80.3 %) patients, while Group 2 comprised 28 (19.7 %) patients. There were no significant differences in demographic data between the groups (p > 0.005). Additionally, there were no statistically significant differences between Group 1 and Group 2 regarding left CAVI (7.92 ± 1.45 vs. 8.72 ± 1.85; p = 0.295), right CAVI (7.89 ± 1.52 vs. 8.67 ± 1.34; p = 0.332), or left or right ankle brachial index (p > 0.005). Conclusions: despite previous studies indicating a significant association between the Naples Prognostic Score and heart failure or acute coronary syndrome, our study did not observe a significant correlation between this score and arterial stiffness assessed by CAVI.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1253-1257"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between fermented dairy consumption, gut microbiota and type 2 diabetes. 发酵乳制品消费、肠道微生物群与 2 型糖尿病之间的关系。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05435
Sergio Vladimir Flores, Ángel Roco-Videla

Introduction:

作品简介:
{"title":"Relationship between fermented dairy consumption, gut microbiota and type 2 diabetes.","authors":"Sergio Vladimir Flores, Ángel Roco-Videla","doi":"10.20960/nh.05435","DOIUrl":"10.20960/nh.05435","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1321"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heuristic evaluation of body mass index with bioimpedance data in the Mexican population. 利用生物阻抗数据对墨西哥人口的体重指数进行启发式评估。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05247
Arnulfo Ramos-Jiménez, Marco Antonio Hernández Lepe, Rosa Patricia Hernández-Torres, Miguel Murguía-Romero

Introduction: Introduction: given the problematic battle against cardio-metabolic diseases and the increase in computational power, different applications are being developed to help estimate overweight and obesity in the population. Objectives: to evaluate the body mass index (BMI) formula (kg/m2), taking body fat measured by bioimpedance as a reference and comparing it with variations of the same form obtained by applying algebraic transformation rules using an artificial intelligence heuristic search method. Material and methods: an artificial intelligence heuristic method was applied to search for the formula that most accurately calculates people's body fat percentage. The formula was generated from body mass and stature, variables used to estimate BMI. Thousands of formulas involving body mass and stature were generated from BMI using transformation rules with algebraic variations and increased and decreased constants. Results: body mass, stature, and body fat percentage data set from 142 female and 150 male participants were used. Body mass and stature were used to classify participants into two classes based on body fat percentage (excessive or adequate, with cutoff points of 30 % for women and 15 % for men). The Youden index guided the search algorithm by evaluating candidate formulas to generate new ones. Among the formulas with the maximum value of the Youden index, Body mass1.1 / Stature2.9, is proposed as the best candidate as an alternative formula to apply instead of the BMI conventional formula. Conclusions: although BMI showed a high Youden index, the AI algorithm found that the W1.1 / H2.9 formula is even more efficient in assessing body fat in men and women.

导言:鉴于与心血管代谢疾病的斗争困难重重,以及计算能力的提高,正在开发不同的应用程序来帮助估计人口中的超重和肥胖情况。目的:评估体重指数(BMI)公式(kg/m2),将生物阻抗测量的体脂作为参考,并与通过人工智能启发式搜索方法应用代数变换规则获得的相同形式的变体进行比较。该公式由体重和身材这两个用于估算体重指数的变量生成。结果:使用了 142 名女性和 150 名男性参与者的体重、身材和体脂百分比数据集。根据体脂百分比,用体重和身材将参与者分为两类(过多或足够,女性的临界点为 30%,男性为 15%)。尤登指数通过评估候选公式来生成新公式,从而指导搜索算法。结论:虽然体重指数显示了较高的尤登指数,但人工智能算法发现,W1.1 / H2.9公式在评估男性和女性体脂方面更为有效。
{"title":"Heuristic evaluation of body mass index with bioimpedance data in the Mexican population.","authors":"Arnulfo Ramos-Jiménez, Marco Antonio Hernández Lepe, Rosa Patricia Hernández-Torres, Miguel Murguía-Romero","doi":"10.20960/nh.05247","DOIUrl":"10.20960/nh.05247","url":null,"abstract":"<p><strong>Introduction: </strong>Introduction: given the problematic battle against cardio-metabolic diseases and the increase in computational power, different applications are being developed to help estimate overweight and obesity in the population. Objectives: to evaluate the body mass index (BMI) formula (kg/m2), taking body fat measured by bioimpedance as a reference and comparing it with variations of the same form obtained by applying algebraic transformation rules using an artificial intelligence heuristic search method. Material and methods: an artificial intelligence heuristic method was applied to search for the formula that most accurately calculates people's body fat percentage. The formula was generated from body mass and stature, variables used to estimate BMI. Thousands of formulas involving body mass and stature were generated from BMI using transformation rules with algebraic variations and increased and decreased constants. Results: body mass, stature, and body fat percentage data set from 142 female and 150 male participants were used. Body mass and stature were used to classify participants into two classes based on body fat percentage (excessive or adequate, with cutoff points of 30 % for women and 15 % for men). The Youden index guided the search algorithm by evaluating candidate formulas to generate new ones. Among the formulas with the maximum value of the Youden index, Body mass1.1 / Stature2.9, is proposed as the best candidate as an alternative formula to apply instead of the BMI conventional formula. Conclusions: although BMI showed a high Youden index, the AI algorithm found that the W1.1 / H2.9 formula is even more efficient in assessing body fat in men and women.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1238-1245"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of body mass index and oxygen saturation with chronic obstructive pulmonary disease grade in patients. 体重指数和血氧饱和度与慢性阻塞性肺病患者等级的关系。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05233
Wenjun Tan, Saiyu Wang, Bingyu Xing, Wenjing Wang, Bao Li, Yaguang Hu

Introduction: Introduction: we aimed to investigate the associations of body mass index (BMI) and oxygen saturation with chronic obstructive pulmonary disease (COPD) grade in COPD patients. Materials and methods: the clinical data of 105 COPD patients admitted to and treated in our hospital during January 2021 and January 2022 were acquired for a retrospective analysis, and grade 1 group [n = 15, subjects presenting forced expiratory volume in one second (FEV1) ≥ 80 % of the predicted value], grade 2 group (n = 32, those with FEV1 ≥ 50 % and < 80 % of the predicted value), grade 3 group (n = 34, those with FEV1 ≥ 30 % and < 50 % of the predicted value), and grade 4 group (n = 24, those with FEV1 < 30 % of the predicted value or with FEV1 < 50 % of the predicted value and concomitant respiratory failure) were set up based on COPD grade. Results and conclusion: the BMI of the 105 patients was 20.39 ± 3.31 kg/m² on average, and it showed differences of statistical significance regarding the subjects with varying COPD grades (p < 0.05). The oxygen saturation was 89.98 ± 4.04 on average in the 105 patients, and it also displayed statistically significant differences among patients with different grades of COPD (p < 0.05). According to pairwise comparison, grade 1 group exhibited the highest oxygen saturation, followed by grade 2, 3, and 4 groups in turn (p < 0.05). Both BMI and oxygen saturation had negative correlations with COPD grade (p < 0.05). In COPD patients, COPD grade is negatively correlated with BMI and oxygen saturation.

导言:我们旨在研究 COPD 患者的体重指数(BMI)和血氧饱和度与慢性阻塞性肺疾病(COPD)分级的关系。材料和方法我们收集了 2021 年 1 月至 2022 年 1 月期间我院收治的 105 名慢性阻塞性肺疾病患者的临床数据,并对其进行了回顾性分析,结果显示:1 级组[n = 15,一秒钟用力呼气容积(FEV1)≥ 预测值 80 % 的受试者]、2 级组(n = 32、根据慢性阻塞性肺病分级设立了 2 级组(n = 32,FEV1 ≥ 50 % 且 < 预测值的 80 %)、3 级组(n = 34,FEV1 ≥ 30 % 且 < 预测值的 50 %)和 4 级组(n = 24,FEV1 < 预测值的 30 % 或 FEV1 < 预测值的 50 % 且合并呼吸衰竭)。结果和结论:105 名患者的体重指数(BMI)平均为 20.39 ± 3.31 kg/m²,不同慢性阻塞性肺病等级的受试者的体重指数差异具有统计学意义(P < 0.05)。105 名患者的血氧饱和度平均为(89.98 ± 4.04),不同慢性阻塞性肺病分级患者的血氧饱和度差异也有统计学意义(P < 0.05)。根据配对比较,1 级组的血氧饱和度最高,其次依次是 2 级、3 级和 4 级组(P < 0.05)。体重指数和血氧饱和度均与慢性阻塞性肺病分级呈负相关(P < 0.05)。在慢性阻塞性肺病患者中,慢性阻塞性肺病分级与体重指数和血氧饱和度呈负相关。
{"title":"Associations of body mass index and oxygen saturation with chronic obstructive pulmonary disease grade in patients.","authors":"Wenjun Tan, Saiyu Wang, Bingyu Xing, Wenjing Wang, Bao Li, Yaguang Hu","doi":"10.20960/nh.05233","DOIUrl":"10.20960/nh.05233","url":null,"abstract":"<p><strong>Introduction: </strong>Introduction: we aimed to investigate the associations of body mass index (BMI) and oxygen saturation with chronic obstructive pulmonary disease (COPD) grade in COPD patients. Materials and methods: the clinical data of 105 COPD patients admitted to and treated in our hospital during January 2021 and January 2022 were acquired for a retrospective analysis, and grade 1 group [n = 15, subjects presenting forced expiratory volume in one second (FEV1) ≥ 80 % of the predicted value], grade 2 group (n = 32, those with FEV1 ≥ 50 % and < 80 % of the predicted value), grade 3 group (n = 34, those with FEV1 ≥ 30 % and < 50 % of the predicted value), and grade 4 group (n = 24, those with FEV1 < 30 % of the predicted value or with FEV1 < 50 % of the predicted value and concomitant respiratory failure) were set up based on COPD grade. Results and conclusion: the BMI of the 105 patients was 20.39 ± 3.31 kg/m² on average, and it showed differences of statistical significance regarding the subjects with varying COPD grades (p < 0.05). The oxygen saturation was 89.98 ± 4.04 on average in the 105 patients, and it also displayed statistically significant differences among patients with different grades of COPD (p < 0.05). According to pairwise comparison, grade 1 group exhibited the highest oxygen saturation, followed by grade 2, 3, and 4 groups in turn (p < 0.05). Both BMI and oxygen saturation had negative correlations with COPD grade (p < 0.05). In COPD patients, COPD grade is negatively correlated with BMI and oxygen saturation.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1147-1152"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical value of vitamin K testing in children aged 1-2 years with vitamin D deficiency rickets. 对 1-2 岁维生素 D 缺乏性佝偻病患儿进行维生素 K 检测的临床价值。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05251
Lipu Jie, Lijuan Niu, Tingting Lu, Qing Sun

Introduction: Objective: to investigate the clinical value of vitamin K testing in children with vitamin D deficiency rickets. Methods: fifty children with vitamin D deficiency rickets admitted to our hospital from March 2021 to March 2022 were recruited as the case group using convenience sampling; and an additional 50 children without bone health diseases during the same period of health checkup were selected as the control group. The relevant indexes between the two groups were compared. Results: there were statistically significant differences between the two groups in the level of 25 hydroxyvitamin D3 [25-(OH)D3], the proportion of breastfeeding, and the proportion of preterm birth (p < 0.001). The levels of vitamin K1 and K2 were lower in the case group than in the control group, and the proportion of those with vitamin K1 deficiency and vitamin K2 deficiency were higher than the control group (p < 0.001) . Positive correlations were found between vitamins K1 and K2 and 25-(OH)D3, blood calcium, and blood phosphorus (p < 0.05); artificial feeding, preterm birth, vitamin K1 deficiency, and vitamin K2 deficiency were risk factors for the development of vitamin D deficiency rickets, and the highest AUC of the combination of each index in predicting the occurrence of vitamin D deficiency rickets was 0.951 (95 % CI: 0.910-0.991). Conclusion: preterm birth, artificial feeding, and vitamin K1 and K2 deficiency are independent risk factors for bone metabolism in children with vitamin D-deficiency rickets. And these risk factors have predictive and diagnostic value in the diagnosis and management of vitamin D deficiency rickets.

摘要】目的:探究维生素K检测在维生素D缺乏性佝偻病患儿中的临床价值。方法:采用方便抽样法,选取我院2021年3月-2022年3月收治的50例维生素D缺乏性佝偻病患儿作为病例组;另选取同期健康体检中无骨骼健康疾病的50例患儿作为对照组。结果:两组患儿的25羟维生素D3[25-(OH)D3]水平、母乳喂养比例、早产比例差异有统计学意义(P<0.001)。病例组的维生素 K1 和 K2 水平低于对照组,维生素 K1 缺乏和维生素 K2 缺乏的比例高于对照组(P < 0.001)。维生素 K1 和 K2 与 25-(OH)D3、血钙和血磷之间呈正相关(P < 0.05);人工喂养、早产、维生素 K1 缺乏和维生素 K2 缺乏是维生素 D 缺乏性佝偻病发生的危险因素,各指标组合预测维生素 D 缺乏性佝偻病发生的最高 AUC 为 0.951(95 % CI:0.910-0.991)。结论:早产、人工喂养、维生素K1和K2缺乏是维生素D缺乏性佝偻病患儿骨代谢的独立危险因素。这些风险因素对维生素 D 缺乏性佝偻病的诊断和治疗具有预测和诊断价值。
{"title":"Clinical value of vitamin K testing in children aged 1-2 years with vitamin D deficiency rickets.","authors":"Lipu Jie, Lijuan Niu, Tingting Lu, Qing Sun","doi":"10.20960/nh.05251","DOIUrl":"10.20960/nh.05251","url":null,"abstract":"<p><strong>Introduction: </strong>Objective: to investigate the clinical value of vitamin K testing in children with vitamin D deficiency rickets. Methods: fifty children with vitamin D deficiency rickets admitted to our hospital from March 2021 to March 2022 were recruited as the case group using convenience sampling; and an additional 50 children without bone health diseases during the same period of health checkup were selected as the control group. The relevant indexes between the two groups were compared. Results: there were statistically significant differences between the two groups in the level of 25 hydroxyvitamin D3 [25-(OH)D3], the proportion of breastfeeding, and the proportion of preterm birth (p < 0.001). The levels of vitamin K1 and K2 were lower in the case group than in the control group, and the proportion of those with vitamin K1 deficiency and vitamin K2 deficiency were higher than the control group (p < 0.001) . Positive correlations were found between vitamins K1 and K2 and 25-(OH)D3, blood calcium, and blood phosphorus (p < 0.05); artificial feeding, preterm birth, vitamin K1 deficiency, and vitamin K2 deficiency were risk factors for the development of vitamin D deficiency rickets, and the highest AUC of the combination of each index in predicting the occurrence of vitamin D deficiency rickets was 0.951 (95 % CI: 0.910-0.991). Conclusion: preterm birth, artificial feeding, and vitamin K1 and K2 deficiency are independent risk factors for bone metabolism in children with vitamin D-deficiency rickets. And these risk factors have predictive and diagnostic value in the diagnosis and management of vitamin D deficiency rickets.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1172-1179"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decision tree model development and in silico validation for avoidable hospital readmissions at 30 days in a pediatric population. 针对儿科人群 30 天内可避免的再住院情况开发决策树模型并进行硅验证。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05277
Nayara Cristina Silva, Laurence Rodrigues do Amaral, Matheus de Souza Gomes, Pedro Luiz Lima Bertarini, Marcelo Keese Albertini, André Ricardo Backes, Geórgia das Graças Pena

Introduction: Background and objective: identifying patients at high risk of avoidable readmission remains a challenge for healthcare professionals. Despite the recent interest in Machine Learning in this topic, studies are scarce and commonly using only black box algorithms. The aim of our study was to develop and validate in silico an interpretable predictive model using a decision tree inference to identify pediatric patients at risk of 30-day potentially avoidable readmissions. Methods: a retrospective cohort study was conducted with all patients under 18 years admitted to a tertiary university hospital. Demographic, clinical and nutritional data were collected from electronic databases. The outcome was the potentially avoidable 30-day readmissions. The J48 algorithm was used to develop the best-fit trees capable of classifying the outcome efficiently. Leave-one-out cross-validation was applied and we computed the area under the receiver operating curve (AUC). Results: the most important attributes of the model were C-reactive protein, hemoglobin and sodium levels, besides nutritional monitoring. We obtained an AUC of 0.65 and accuracy of 63.3 % for the full training and leave-one-out cross-validation. Conclusion: our model allows the identification of 30-day potentially avoidable readmissions through practical indicators facilitating timely interventions by the medical team, and might contribute to reduce this outcome.

背景和目的:识别可避免再入院的高风险患者仍是医疗专业人员面临的一项挑战。尽管近来机器学习在这一领域备受关注,但相关研究却很少,而且通常只使用黑盒算法。我们的研究目的是利用决策树推理,开发并验证一个可解释的预测模型,以识别有 30 天潜在可避免再入院风险的儿科患者。方法:我们对一家三级大学医院收治的所有 18 岁以下患者进行了一项回顾性队列研究。从电子数据库中收集了人口统计学、临床和营养数据。研究结果为可避免的 30 天再入院率。研究人员使用 J48 算法开发了能够对结果进行有效分类的最佳拟合树。结果:除营养监测外,该模型最重要的属性是 C 反应蛋白、血红蛋白和钠水平。结论:我们的模型可以通过实用指标识别 30 天内可能避免的再入院情况,便于医疗团队及时干预,并可能有助于减少这一结果。
{"title":"Decision tree model development and in silico validation for avoidable hospital readmissions at 30 days in a pediatric population.","authors":"Nayara Cristina Silva, Laurence Rodrigues do Amaral, Matheus de Souza Gomes, Pedro Luiz Lima Bertarini, Marcelo Keese Albertini, André Ricardo Backes, Geórgia das Graças Pena","doi":"10.20960/nh.05277","DOIUrl":"10.20960/nh.05277","url":null,"abstract":"<p><strong>Introduction: </strong>Background and objective: identifying patients at high risk of avoidable readmission remains a challenge for healthcare professionals. Despite the recent interest in Machine Learning in this topic, studies are scarce and commonly using only black box algorithms. The aim of our study was to develop and validate in silico an interpretable predictive model using a decision tree inference to identify pediatric patients at risk of 30-day potentially avoidable readmissions. Methods: a retrospective cohort study was conducted with all patients under 18 years admitted to a tertiary university hospital. Demographic, clinical and nutritional data were collected from electronic databases. The outcome was the potentially avoidable 30-day readmissions. The J48 algorithm was used to develop the best-fit trees capable of classifying the outcome efficiently. Leave-one-out cross-validation was applied and we computed the area under the receiver operating curve (AUC). Results: the most important attributes of the model were C-reactive protein, hemoglobin and sodium levels, besides nutritional monitoring. We obtained an AUC of 0.65 and accuracy of 63.3 % for the full training and leave-one-out cross-validation. Conclusion: our model allows the identification of 30-day potentially avoidable readmissions through practical indicators facilitating timely interventions by the medical team, and might contribute to reduce this outcome.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1180-1187"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The necessary and complex biopsychosocial view of food]. [必要而复杂的生物心理社会食物观]。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05430
Claudia Andrea Troncoso Pantoja

Introduction:

作品简介:
{"title":"[The necessary and complex biopsychosocial view of food].","authors":"Claudia Andrea Troncoso Pantoja","doi":"10.20960/nh.05430","DOIUrl":"10.20960/nh.05430","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1319-1320"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Update on the consensus for hospital coding according to GLIM criteria: an approach adapted to hospital complexity]. [根据 GLIM 标准进行医院编码的最新共识:一种适应医院复杂性的方法]。
IF 2.5 4区 医学 Q3 BUSINESS Pub Date : 2024-12-19 DOI: 10.20960/nh.05618
Gabriel Olveira

Introduction:

作品简介:
{"title":"[Update on the consensus for hospital coding according to GLIM criteria: an approach adapted to hospital complexity].","authors":"Gabriel Olveira","doi":"10.20960/nh.05618","DOIUrl":"10.20960/nh.05618","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"1137-1138"},"PeriodicalIF":2.5,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142687750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nutricion hospitalaria
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1